1120 related articles for article (PubMed ID: 23861532)
1. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
[TBL] [Abstract][Full Text] [Related]
2. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
[TBL] [Abstract][Full Text] [Related]
3. Psoriatic arthritis and spondyloarthritis assessment and management update.
Mease P
Curr Opin Rheumatol; 2013 May; 25(3):287-96. PubMed ID: 23492739
[TBL] [Abstract][Full Text] [Related]
4. Biological therapies in the spondyloarthritides--the current state.
Braun J; Sieper J
Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of ankylosing spondylitis and undifferentiated spondyloarthritis with TNF alpha-antagonists].
Brandt J; Sieper J; Braun J
Z Rheumatol; 2003 Jun; 62(3):218-27. PubMed ID: 12827397
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
7. Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis.
Carneiro S; Bortoluzzo A; Gonçalves C; Silva JA; Ximenes AC; Bértolo M; Ribeiro SL; Keiserman M; Skare T; Menin R; Azevedo V; Vieira W; Albuquerque E; Bianchi W; Bonfiglioli R; Campanholo C; Carvalho HM; Costa Id; Duarte A; Kohem C; Leite N; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Valim V; Sampaio-Barros PD
J Rheumatol; 2013 Oct; 40(10):1719-25. PubMed ID: 23858049
[TBL] [Abstract][Full Text] [Related]
8. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis.
Paramarta JE; De Rycke L; Heijda TF; Ambarus CA; Vos K; Dinant HJ; Tak PP; Baeten DL
Ann Rheum Dis; 2013 Nov; 72(11):1793-9. PubMed ID: 23139265
[TBL] [Abstract][Full Text] [Related]
10. Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort.
Tournadre A; Pereira B; Lhoste A; Dubost JJ; Ristori JM; Claudepierre P; Dougados M; Soubrier M
Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1482-9. PubMed ID: 23463610
[TBL] [Abstract][Full Text] [Related]
11. Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort.
Canouï-Poitrine F; Poulain C; Molto A; Le Thuaut A; Lafon C; Farrenq V; Ferkal S; Le Corvoisier P; Ghaleh B; Bastuji-Garin S; Fautrel B; Dougados M; Claudepierre P
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1395-402. PubMed ID: 24664935
[TBL] [Abstract][Full Text] [Related]
12. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
[TBL] [Abstract][Full Text] [Related]
13. Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology.
Wendling D; Dougados M; Berenbaum F; Brocq O; Schaeverbeke T; Mazieres B; Marcelli C; Leparc JM; Bertin P; Robin M; Sibilia J; Lafforgue P; Prati C; Combe B; Gottenberg JE;
J Rheumatol; 2012 Dec; 39(12):2327-31. PubMed ID: 22896028
[TBL] [Abstract][Full Text] [Related]
14. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.
Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Rudwaleit M; Sieper J; Braun J
J Rheumatol; 2004 Mar; 31(3):531-8. PubMed ID: 14994401
[TBL] [Abstract][Full Text] [Related]
15. [Axial spondyloarthritis and ankylosing spondylitis].
Nordström D; Kauppi M
Duodecim; 2010; 126(12):1467-74. PubMed ID: 20617750
[TBL] [Abstract][Full Text] [Related]
16. Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden Early Arthritis cohort.
van den Berg R; van Gaalen F; van der Helm-van Mil A; Huizinga T; van der Heijde D
Ann Rheum Dis; 2012 Aug; 71(8):1366-9. PubMed ID: 22504563
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for the treatment of axial and peripheral spondyloarthritis.
Braun J; Kiltz U; Heldmann F; Baraliakos X
Expert Opin Emerg Drugs; 2015 Mar; 20(1):1-14. PubMed ID: 25575936
[TBL] [Abstract][Full Text] [Related]
18. Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis.
Skare TL; Bortoluzzo AB; Gonçalves CR; Braga da Silva JA; Ximenes AC; Bértolo MB; Ribeiro SL; Keiserman M; Menin R; Carneiro S; Azevedo VF; Vieira WP; Albuquerque EN; Bianchi WA; Bonfiglioli R; Campanholo C; Carvalho HM; Costa IP; Duarte AP; Gavi MB; Kohem CL; Leite NH; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Sampaio-Barros PD
J Rheumatol; 2012 Jan; 39(1):141-7. PubMed ID: 22045839
[TBL] [Abstract][Full Text] [Related]
19. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.
van der Heijde D; Sieper J; Maksymowych WP; Dougados M; Burgos-Vargas R; Landewé R; Rudwaleit M; Braun J;
Ann Rheum Dis; 2011 Jun; 70(6):905-8. PubMed ID: 21540200
[TBL] [Abstract][Full Text] [Related]
20. A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.
Michelsen B; Fiane R; Diamantopoulos AP; Soldal DM; Hansen IJ; Sokka T; Kavanaugh A; Haugeberg G
PLoS One; 2015; 10(4):e0123582. PubMed ID: 25853482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]